Protein misfolding & human diseases (2016/2017)

Codice insegnamento
4S003664
Docente
Paola Dominici
Coordinatore
Paola Dominici
crediti
6
Settore disciplinare
BIO/10 - BIOCHIMICA
Lingua di erogazione
Inglese
Periodo
II sem. dal 1-mar-2017 al 9-giu-2017.

Orario lezioni

II sem.
Giorno Ora Tipo Luogo Note
lunedì 13.30 - 15.30 lezione Aula G  
mercoledì 9.30 - 11.30 lezione Aula H  

Obiettivi formativi

This course aims to provide information on conformational disease, protein quality control system, chaperone,inherited disorders.
In particular, students will gain familiarity with PRINCIPLES OF PROTEIN MISFOLDING;PROTEIN MISFOLDING DISEASE;MEDICAL ASPECTS OF DISEASE: DIAGNOSIS AND CURRENT THERAPIES

Programma

PRINCIPLES OF PROTEIN MISFOLDING
Why Proteins Misfold
Endoplasmic Reticulum Stress and Oxidative Stress:
Mechanisms and Link to Disease
Role of Molecular Chaperones in Protein Folding
Kinetic Models for Protein Misfolding and Association
Autophagy: An Alternative Degradation Mechanism
for Misfolded Proteins
Role of Posttranslational Modifications in Amyloid Formation
Caenorhabditis elegans as a Model System to Study the
Biology of Protein Aggregation and Toxicity
Animal Models to Study the Biology of Amyloid-b
Protein Misfolding in Alzheimer Disease

PROTEIN MISFOLDING DISEASE: GAIN-OF-FUNCTION AND LOSS-OF-FUNCTION DISEASES
Alzheimer Disease: Protein Misfolding, Model Systems,
and Experimental Therapeutics
Prion Disease Therapy
Misfolding and Aggregation in Huntington Disease
Systemic Amyloidoses
Copper–Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis
Alpha-1-Antitrypsin Deficiency
Folding Biology of Cystic Fibrosis: A Consortium-Based Approach to Disease
Cataract as a Protein-Aggregation Disease

MEDICAL ASPECTS OF DISEASE: DIAGNOSIS AND CURRENT THERAPIES
Imaging of Misfolded Proteins
Diagnosis of Systemic Amyloid Diseases
Identification of Biomarkers for Diagnosis of Amyloid Diseases: Quantitative Free Light-Chain Assays
Current and Future Therapies for Alzheimer Disease
Current Therapies for Light-Chain Amyloidosis
Identifying Targets in a-Synuclein Metabolism to Treat
Parkinson Disease and Related Disorders

Modalità d'esame

Scritto. Domande aperte su argomenti del programma.

Opinione studenti frequentanti - 2016/2017